“…The National Strategy for the Reorganization of Arterial Hypertension and Diabetes Mellitus Care implements, through this Program, the register and follow-up of hypertensive and diabetic patients detected by SUS and the free supply of five essential medicines: captopril 25mg, hydroclorotiazide 25mg and propranolol 40mg for hypertension treatment; glibenclamide 5mg and metformin 850mg for diabetes treatment, as well as NPH-100 insulin systematically distributed within the public health service 13 through the Program of Strategic Medicines 14 . National publications about household-level medicine access are scant, the methodologies employed vary, access is measured regardless of consumption conditions 15,16,17,18 and some studies exclude chronic patients 14 . Other studies have evaluated medicine access based on the availability of medicine in health services 2,3,4,5,19 .…”